{"id":13023,"date":"2022-04-05T11:48:00","date_gmt":"2022-04-05T09:48:00","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=13023"},"modified":"2026-03-03T10:56:01","modified_gmt":"2026-03-03T09:56:01","slug":"medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/","title":{"rendered":"Communiqu\u00e9 de presse:        \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p> B\u00e2le, le 5 avril 2022 <\/p>\n\n\n\n<p class=\"is-style-paragraph-lead-text\">\u00c0 partir d\u2019aujourd\u2019hui, 5&nbsp;avril 2022, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Moderna. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le rapport 2021 a \u00e9galement \u00e9t\u00e9 pr\u00e9sent\u00e9. Il permet de constater que l\u2019industrie pharmaceutique prend au s\u00e9rieux sa responsabilit\u00e9 sociale pour un d\u00e9veloppement durable et contribue de mani\u00e8re d\u00e9cisive \u00e0 l\u2019am\u00e9lioration de la sant\u00e9 \u00e0 l\u2019\u00e9chelon mondial. <\/p>\n\n\n\n<p>Avec leurs diff\u00e9rents domaines th\u00e9rapeutiques,\nles entreprises membres d\u2019Interpharma apportent une contribution importante \u00e0\nl\u2019excellente qualit\u00e9 de la prise en charge sanitaire en Suisse. Elles\nd\u00e9veloppent et produisent des m\u00e9dicaments qui soulagent les souffrances et\nsauvent des vies dans le monde entier. En 2020, les membres d\u2019Interpharma ont\nainsi investi environ sept milliards de francs dans les activit\u00e9s de recherche\net d\u00e9veloppement en Suisse. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale qui s\u2019est tenue\naujourd\u2019hui, Interpharma a\naccueilli un nouveau membre, Moderna, entreprise pharmaceutique qui\nd\u00e9veloppe des m\u00e9dicaments \u00e0 base d\u2019ARN messager contre un large \u00e9ventail de\nmaladies et de sympt\u00f4mes. En font potentiellement partie de nouveaux\nm\u00e9dicaments \u00e0 base d\u2019ARNm pour le traitement de maladies infectieuses, de\ncancers, de maladies rares ou de maladies cardio-vasculaires. En Suisse, on\nconna\u00eet Moderna surtout pour son vaccin contre le COVID-19.<\/p>\n\n\n\n<p>\u00abNous sommes tr\u00e8s heureux d\u2019accueillir\nModerna, un leader dans le domaine de la recherche pharmaceutique, en tant que\nnouveau membre\u00bb, d\u00e9clare Ren\u00e9 Buholzer, directeur d\u2019Interpharma. \u00abL\u2019adh\u00e9sion de\nModerna renforce encore la position d\u2019Interpharma en tant qu\u2019organisation\nfa\u00eeti\u00e8re des entreprises pharmaceutiques pratiquant la recherche en Suisse.\nAujourd\u2019hui, les entreprises membres d\u2019Interpharma repr\u00e9sentent plus de 90% de\nparts du march\u00e9 suisse des m\u00e9dicaments prot\u00e9g\u00e9s par un brevet et rembours\u00e9s par\nles caisses-maladie, nous sommes donc tr\u00e8s repr\u00e9sentatifs de l\u2019industrie\npharmaceutique pratiquant la recherche\u00bb, ajoute-t-il.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Rapport\nannuel 2021: notre contribution au d\u00e9veloppement durable<\/strong><\/h2>\n\n\n\n<p>Pour l\u2019industrie pharmaceutique, ce sont\nles patientes et patients, et donc leur sant\u00e9 et leur bien-\u00eatre, qui sont au\npremier plan. C\u2019est pour cela qu\u2019elle travaille et fait de la recherche. En\nm\u00eame temps, les entreprises membres d\u2019Interpharma apportent une contribution\nessentielle pour l\u2019avenir. Elles assument leurs responsabilit\u00e9s pour la\ndurabilit\u00e9 en Suisse et dans le monde entier. Interpharma pr\u00e9sente cet\nengagement dans son rapport annuel publi\u00e9 ce jour et le place dans le contexte\ndes Objectifs de d\u00e9veloppement durable (ODD) de l\u2019ONU. <\/p>\n\n\n\n<p>Les entreprises pharmaceutiques implant\u00e9es\nen Suisse contribuent tout particuli\u00e8rement aux trois objectifs de l\u2019ONU \u00abBonne\nsant\u00e9 et bien-\u00eatre\u00bb, \u00ab\u00c9galit\u00e9 entre les sexes\u00bb et \u00abMesures relatives \u00e0 la lutte\ncontre les changements climatiques\u00bb, sans pour autant que l\u2019engagement large et\nmultiple des entreprises membres se limite \u00e0 ces trois domaines.<\/p>\n\n\n\n<p>La th\u00e9matique d\u2019un avenir p\u00e9renne concerne\ntout le monde. Une direction d\u2019entreprise responsable misera \u00e0 l\u2019avenir sur un\nmod\u00e8le commercial durable, tenant compte des besoins individuels, renfor\u00e7ant\nles espaces de vie sociaux et contribuant \u00e0 sauvegarder la nature. Cela va bien\nau-del\u00e0 de mesures ponctuelles et b\u00e9n\u00e9ficie \u00e0 l\u2019environnement, \u00e0 la soci\u00e9t\u00e9,\nmais aussi aux entreprises elles-m\u00eames.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>B\u00e2le, le 5 avril 2022 \u00c0 partir d\u2019aujourd\u2019hui, 5&nbsp;avril 2022, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Moderna. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le rapport 2021 a \u00e9galement \u00e9t\u00e9 pr\u00e9sent\u00e9. Il permet de constater que l\u2019industrie pharmaceutique prend au s\u00e9rieux sa [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2246,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[120,122],"class_list":["post-13023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-innovation-fr","tag-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse:    \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse:    \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma\" \/>\n<meta property=\"og:description\" content=\"B\u00e2le, le 5 avril 2022 \u00c0 partir d\u2019aujourd\u2019hui, 5&nbsp;avril 2022, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Moderna. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le rapport 2021 a \u00e9galement \u00e9t\u00e9 pr\u00e9sent\u00e9. Il permet de constater que l\u2019industrie pharmaceutique prend au s\u00e9rieux sa [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-05T09:48:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:56:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma\",\"datePublished\":\"2022-04-05T09:48:00+00:00\",\"dateModified\":\"2026-03-03T09:56:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\"},\"wordCount\":575,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg\",\"keywords\":[\"Innovation\",\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\",\"url\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\",\"name\":\"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg\",\"datePublished\":\"2022-04-05T09:48:00+00:00\",\"dateModified\":\"2026-03-03T09:56:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg\",\"width\":2048,\"height\":1536},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse:    \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse:    \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma","og_description":"B\u00e2le, le 5 avril 2022 \u00c0 partir d\u2019aujourd\u2019hui, 5&nbsp;avril 2022, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Moderna. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le rapport 2021 a \u00e9galement \u00e9t\u00e9 pr\u00e9sent\u00e9. Il permet de constater que l\u2019industrie pharmaceutique prend au s\u00e9rieux sa [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/","og_site_name":"Interpharma","article_published_time":"2022-04-05T09:48:00+00:00","article_modified_time":"2026-03-03T09:56:01+00:00","og_image":[{"width":2048,"height":1536,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma","datePublished":"2022-04-05T09:48:00+00:00","dateModified":"2026-03-03T09:56:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/"},"wordCount":575,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg","keywords":["Innovation","Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/","url":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/","name":"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg","datePublished":"2022-04-05T09:48:00+00:00","dateModified":"2026-03-03T09:56:01+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/04\/Annual-Conference-2022.jpeg","width":2048,"height":1536},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-fuehrend-in-der-entwicklung-von-mrna-medikamenten-moderna-wird-mitglied-bei-interpharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: \u00c0 la pointe du d\u00e9veloppement de m\u00e9dicaments \u00e0 base d\u2019ARNm: Moderna rejoint Interpharma"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/13023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=13023"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/13023\/revisions"}],"predecessor-version":[{"id":13024,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/13023\/revisions\/13024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/2246"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=13023"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=13023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}